結紮器材市場 - 全球產業規模、佔有率、趨勢、機會、預測：按產品、應用、手術類型、最終用途、地區和競爭對手分類，2021-2031年

全球結紮器市場預計將從 2025 年的 20.7 億美元成長到 2031 年的 31.1 億美元，複合年成長率為 7.02%。

這些專用醫療器械對於外科醫生在手術過程中封閉組織束和血管、止血以及防止內滲至關重要。市場成長的主要驅動力是全球開放性手術和微創手術數量的不斷增加。人口老化以及心血管疾病和癌症等慢性疾病發生率的上升，使得這一趨勢不可避免。例如，美國癌症協會估計，到2025年，美國將新增2,041,910例癌症病例，這進一步推動了這些器械在腫瘤切除等重要手術中需求的成長。

儘管對這些設備的需求日益成長，但由於一次性器械的高昂採購成本，市場面臨巨大的障礙。這些成本會對醫院預算造成沉重負擔，從而限制了在財政拮据的醫療系統中進行採購。儘管全球醫療保健領域對高效止血設備的臨床需求持續成長，但這項經濟因素仍是可能限制市場准入的重大挑戰。

市場促進因素

微創手術的日益普及是全球結紮器械市場的主要驅動力。為了改善患者預後並縮短住院時間，外科醫生擴大採用機器人輔助手術和腹腔鏡手術，這些手術需要使用專為狹窄空間設計的專用結紮器械。這些手術需要精準止血，直接推動了內視鏡結紮夾和結紮器械的購買。根據直覺外科公司（Intuitive Surgical）於2025年1月發布的2024年第四季及全年收益快報，2024年全球使用達文西手術系統的手術量同比成長約17%，顯示在複雜手術中，人們越來越依賴使用結紮器進行有效組織控制的先進技術。

同時，受慢性病和文明病率上升的推動，全球需要止血管理的介入手術數量正在增加。在心血管疾病等疾病中，手術修復往往至關重要，因此，無論是開放性手術手術或微創手術，對結紮器械的需求仍然強勁。根據美國心臟協會於2024年1月發布的《2024年心臟病和中風統計數據》，心血管疾病仍是全球首要死因，每年約有1,991萬人死於心血管疾病。為了滿足這一手術需求，領先的醫療技術公司公佈了強勁的財務表現。例如，Medtronic公司於2024年5月發布的《2024會計年度財務業績報告》顯示，其醫療手術產品組合的收入達到84.17億美元，較去年同期成長5.4%。

市場挑戰

一次性結紮器械的高昂採購成本是全球結紮器械市場擴張的主要障礙。雖然這些一次性器械對於感染控制和提高手術效率至關重要，但其高昂的價格給醫療機構帶來了沉重的經濟負擔。當醫院面臨預算緊張時，持續採購大量一次性耗材的成本迫使管理者大幅削減採購，或選擇更便宜但較舊的替代方案。這種經濟負擔在資源本就有限的小規模診所和發展中地區尤其嚴重，直接導致這些地區無法採購到先進的結紮器械。

近期產業數據顯示，醫療機構營運成本飆升，進一步印證了這種經濟壓力。根據美國醫院協會2024年發布的《醫療服務成本》報告，耗材成本佔醫院總支出的13%，而醫院總支出增加了5.1%，遠高於整體通膨率。耗材上的過度支出限制了用於引進昂貴手術器械的資金。因此，隨著醫療系統優先控制成本，市場成長放緩，採用更新、更昂貴的結紮技術也被擱置。

市場趨勢

隨著醫療機構擴大將低至中等複雜程度的手術從傳統醫院轉移到門診手術中心（ASC），這種轉變正在從根本上改變結紮器械的使用模式。這種結構性轉變的驅動力在於提高營運效率和控制成本，促使門診機構採購專業且經濟高效的結紮器械，以確保快速止血，而無需承擔醫院大規模庫存的額外開銷。由於這些中心優先考慮高處理能力，因此對可靠的、一次性使用的血管夾和專為簡化工作流程而設計的施用器的需求正在加速成長。領先的醫療機構營運商的財務數據也印證了這項轉變。根據泰尼特醫療（Tenet Healthcare）於2025年2月發布的“2024年第四季度及全年業績累計”，由聯合外科夥伴國際公司（United Surgical Partners International）運營的門診運營部門2024年的淨營業收入為45億美元，較上年度的39億美元大幅成長。這反映了對門診手術護理日益成長的需求。

同時，內視鏡結紮技術的進步正在提升市場價值，因為它克服了傳統金屬夾在複雜微創手術中的限制。製造商正積極研發先進的聚合物和自鎖夾，這些夾子具有更高的安全性和觸覺回饋。這些特性對於防止複雜腹腔鏡手術過程中夾子脫落至關重要。這項技術革新正促使外科醫生從傳統的機械方法轉向現代化的工程結紮解決方案，從而最大限度地減少血管損傷和手術時間。這些先進器械的強勁商業性接受度從公司近期的業績指標中可見一斑。根據泰利福（Teleflex）於2025年3月發布的“2024年第四季度財務業績報告”，其外科部門在不外匯影響的情況下實現了12.3%的收入成長，這主要歸功於公司先進結紮產品組合和手術器械的持續普及。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：結紮器械的全球市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 產品特定（適用設備、配件）
  • 依應用領域（消化/腹部手術、婦科手術、心臟/胸腔外科手術、泌尿系統手術、其他）
  • 手術類型（微創手術、開放性手術）
  • 依最終用戶（醫院、門診手術中心）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美結紮器械市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲結紮器械市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區結紮器材市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲結紮器材市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲結紮器械市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章 全球結紮器材市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Medtronic Plc
• The Cooper Companies, Inc.
• Conmed Corporation
• B Braun Melsungen AG
• Teleflex Incorporated
• Olympus Corporation
• Ethicon, Inc.
• Sinolinks Medical Innovatoin, Inc.
• Duomed Group
• Leo Medical Co.,Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Ligation Devices Market is projected to expand from a valuation of USD 2.07 Billion in 2025 to reach USD 3.11 Billion by 2031, registering a Compound Annual Growth Rate (CAGR) of 7.02%. These specialized medical instruments are essential for surgeons to seal tissue bundles or blood vessels, thereby achieving hemostasis and preventing internal leakage during medical interventions. The market's growth is largely driven by the rising global volume of both open and minimally invasive surgeries, a trend necessitated by an aging demographic and the increasing incidence of chronic conditions such as cardiovascular diseases and cancer. For instance, the American Cancer Society estimates that 2,041,910 new cancer cases will be diagnosed in the United States in 2025, underscoring the growing need for surgical tumor removal where these tools are critical.

Despite the rising demand for these devices, the market faces a significant hurdle regarding the high acquisition costs of disposable instruments. These costs can place a heavy burden on hospital budgets, thereby restricting procurement within healthcare systems that operate under financial constraints. This economic factor remains a notable challenge, potentially limiting market access even as the clinical necessity for efficient hemostatic devices continues to grow across the global healthcare landscape.

Market Driver

The widespread adoption of minimally invasive surgical procedures serves as a primary catalyst for the global ligation devices market. Driven by the goal of improving patient outcomes and reducing hospital stays, surgeons are increasingly utilizing robotic-assisted and laparoscopic techniques that require specialized ligation instruments designed for narrow access. These procedures demand precise hemostasis, directly boosting the procurement of endoscopic clips and appliers. Data from Intuitive Surgical's "Preliminary Fourth Quarter and Full Year 2024 Results" in January 2025 indicates that worldwide procedures using da Vinci systems grew by approximately 17% in 2024 compared to the previous year, highlighting the expanding reliance on advanced technologies utilizing ligation devices for effective tissue management during complex operations.

Simultaneously, the rising global prevalence of chronic and lifestyle-related diseases is increasing the volume of surgical interventions that require hemostatic control. Conditions such as cardiovascular diseases often mandate surgical repair, sustaining a high baseline demand for ligation tools in both open and minimally invasive settings. According to the American Heart Association's "Heart Disease and Stroke Statistics 2024 Update" from January 2024, cardiovascular disease remains the leading cause of death globally, accounting for approximately 19.91 million deaths annually. To support this surgical demand, major medical technology companies report strong financial performance; for example, Medtronic's May 2024 "Fiscal Year 2024 Financial Results" showed that its Medical Surgical Portfolio generated $8.417 billion in revenue, reflecting a 5.4% increase over the prior year.

Market Challenge

The high acquisition costs of disposable ligation instruments constitute a significant barrier to the expansion of the Global Ligation Devices Market. Although these single-use tools are vital for infection control and operational efficiency, their premium pricing creates substantial financial pressure on healthcare facilities. When hospitals face tight budget constraints, the recurring expense of purchasing high-volume disposable supplies forces administrators to strictly limit procurement or opt for less expensive, older alternatives. This financial strain is particularly acute in smaller clinics and developing regions, where resource allocation is already restricted, directly reducing the volume of advanced ligation devices purchased.

This economic pressure is further evidenced by recent industry data highlighting the escalating operational costs faced by medical providers. The American Hospital Association's "Cost of Caring" report released in 2024 indicates that supply costs accounted for 13% of total hospital expenses, with overall hospital expenses growing by 5.1%, significantly outpacing the general inflation rate. Such elevated spending on supplies limits the capital available for adopting premium surgical tools. Consequently, the market experiences dampened growth rates as healthcare systems prioritize cost containment over the adoption of newer, albeit more expensive, ligation technologies.

Market Trends

The migration of procedures to Ambulatory Surgical Centers is fundamentally reshaping the consumption patterns of ligation devices, as healthcare providers increasingly move low-to-mid complexity surgeries out of traditional hospital settings. This structural shift is driven by the need for operational efficiency and cost containment, prompting ambulatory facilities to procure specialized, cost-effective ligation tools that ensure rapid hemostasis without the overhead of extensive hospital inventory. These centers prioritize high-volume throughput, thereby accelerating the demand for reliable, single-fire ligation clips and applicators designed for streamlined workflows. This transition is substantiated by financial data from major facility operators; according to Tenet Healthcare's "Fourth Quarter and Full Year 2024 Results" in February 2025, the Ambulatory Care segment operated by United Surgical Partners International generated $4.5 billion in net operating revenues for 2024, a significant increase from $3.9 billion the previous year, reflecting the intensifying volume of outpatient surgical care.

Concurrently, advancements in endoscopic ligation techniques are fueling market value by addressing the limitations of traditional metallic clips in complex minimally invasive procedures. Manufacturers are aggressively innovating to develop advanced polymer and self-locking clips that offer superior security and tactile feedback, which are critical for preventing dislodgement during intricate laparoscopic maneuvers. This technological evolution encourages surgeons to upgrade from legacy mechanical methods to modern, engineered ligation solutions that minimize vessel trauma and operative time. The robust commercial reception of these advanced instruments is evident in recent corporate performance metrics; Teleflex Incorporated's "Fourth Quarter 2024 Earnings Report" from March 2025 noted that its Surgical segment achieved a 12.3% growth in revenue on a constant currency basis, a performance largely attributed to the sustained adoption of its advanced ligation portfolio and surgical instruments.

Key Market Players

• Medtronic Plc
• The Cooper Companies, Inc.
• Conmed Corporation
• B Braun Melsungen AG
• Teleflex Incorporated
• Olympus Corporation
• Ethicon, Inc.
• Sinolinks Medical Innovatoin, Inc.
• Duomed Group
• Leo Medical Co.,Ltd.

Report Scope

In this report, the Global Ligation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ligation Devices Market, By Product

• Appliers
• Accessories

Ligation Devices Market, By Application

• Gastrointestinal and abdominal surgery
• Gynecological surgery
• Cardiothoracic surgery
• Urological Surgery
• Other

Ligation Devices Market, By Procedure Type

• MIS
• Open Surgery

Ligation Devices Market, By End-use

• Hospitals
• Ambulatory Surgical Centers

Ligation Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ligation Devices Market.

Available Customizations:

Global Ligation Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Ligation Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Appliers, Accessories)
  • 5.2.2. By Application (Gastrointestinal and abdominal surgery, Gynecological surgery, Cardiothoracic surgery, Urological Surgery, Other)
  • 5.2.3. By Procedure Type (MIS, Open Surgery)
  • 5.2.4. By End-use (Hospitals, Ambulatory Surgical Centers)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Ligation Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Procedure Type
  • 6.2.4. By End-use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Ligation Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Procedure Type
      • 6.3.1.2.4. By End-use
  • 6.3.2. Canada Ligation Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Procedure Type
      • 6.3.2.2.4. By End-use
  • 6.3.3. Mexico Ligation Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Procedure Type
      • 6.3.3.2.4. By End-use

7. Europe Ligation Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Procedure Type
  • 7.2.4. By End-use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Ligation Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Procedure Type
      • 7.3.1.2.4. By End-use
  • 7.3.2. France Ligation Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Procedure Type
      • 7.3.2.2.4. By End-use
  • 7.3.3. United Kingdom Ligation Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Procedure Type
      • 7.3.3.2.4. By End-use
  • 7.3.4. Italy Ligation Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Procedure Type
      • 7.3.4.2.4. By End-use
  • 7.3.5. Spain Ligation Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Procedure Type
      • 7.3.5.2.4. By End-use

8. Asia Pacific Ligation Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Procedure Type
  • 8.2.4. By End-use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Ligation Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Procedure Type
      • 8.3.1.2.4. By End-use
  • 8.3.2. India Ligation Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Procedure Type
      • 8.3.2.2.4. By End-use
  • 8.3.3. Japan Ligation Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Procedure Type
      • 8.3.3.2.4. By End-use
  • 8.3.4. South Korea Ligation Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Procedure Type
      • 8.3.4.2.4. By End-use
  • 8.3.5. Australia Ligation Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Procedure Type
      • 8.3.5.2.4. By End-use

9. Middle East & Africa Ligation Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Procedure Type
  • 9.2.4. By End-use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Ligation Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Procedure Type
      • 9.3.1.2.4. By End-use
  • 9.3.2. UAE Ligation Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Procedure Type
      • 9.3.2.2.4. By End-use
  • 9.3.3. South Africa Ligation Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Procedure Type
      • 9.3.3.2.4. By End-use

10. South America Ligation Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Procedure Type
  • 10.2.4. By End-use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Ligation Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Procedure Type
      • 10.3.1.2.4. By End-use
  • 10.3.2. Colombia Ligation Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Procedure Type
      • 10.3.2.2.4. By End-use
  • 10.3.3. Argentina Ligation Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Procedure Type
      • 10.3.3.2.4. By End-use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Ligation Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic Plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. The Cooper Companies, Inc.
• 15.3. Conmed Corporation
• 15.4. B Braun Melsungen AG
• 15.5. Teleflex Incorporated
• 15.6. Olympus Corporation
• 15.7. Ethicon, Inc.
• 15.8. Sinolinks Medical Innovatoin, Inc.
• 15.9. Duomed Group
• 15.10. Leo Medical Co.,Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer